NO951966L - - Google Patents

Info

Publication number
NO951966L
NO951966L NO951966A NO951966A NO951966L NO 951966 L NO951966 L NO 951966L NO 951966 A NO951966 A NO 951966A NO 951966 A NO951966 A NO 951966A NO 951966 L NO951966 L NO 951966L
Authority
NO
Norway
Prior art keywords
mofene
mycophenolate
angioplasty
stenosis
administering
Prior art date
Application number
NO951966A
Other languages
Norwegian (no)
Other versions
NO951966D0 (en
Inventor
Elisabeth B Fraser-Smith
Anthony C Allison
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1992/009932 external-priority patent/WO1994012184A1/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO951966L publication Critical patent/NO951966L/no
Publication of NO951966D0 publication Critical patent/NO951966D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Stenosis, spesielt restenosis forbundet med angioplasti- eller hjerteforbiled- ningsoperasjoner, behandles ved admini- strering av en terapeutisk effektiv mengde mykofenolsyre, mykofenolat-mofe- til eller et i farmasøytisk henseende akseptabelt salt eller derivat derav.Stenosis, especially restenosis associated with angioplasty or heart bypass surgery, is treated by administering a therapeutically effective amount of mycophenolic acid, mycophenolate mofene or a pharmaceutically acceptable salt or derivative thereof.

NO951966A 1992-11-24 1995-05-18 NO951966D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98083892A 1992-11-24 1992-11-24
CA002144189A CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis
PCT/US1992/009932 WO1994012184A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis

Publications (2)

Publication Number Publication Date
NO951966L true NO951966L (en) 1995-05-18
NO951966D0 NO951966D0 (en) 1995-05-18

Family

ID=27169974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951966A NO951966D0 (en) 1992-11-24 1995-05-18

Country Status (2)

Country Link
CA (1) CA2144189A1 (en)
NO (1) NO951966D0 (en)

Also Published As

Publication number Publication date
CA2144189A1 (en) 1994-06-09
NO951966D0 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
NO180407C (en) Use of 1,3-oxathiolannucleoside analogues in the manufacture of a medicament for the treatment of hepatitis B
NO179582C (en) Analogous Process for Preparing Therapeutically Active Hydroxamic Acid and N-Hydroxyurea Derivatives
MX9603479A (en) DERIVATIVES OF 4-AMINO OF MYCOPHENOLIC ACID WITH IMMUNOSUPPRESSIVE ACTIVITY.
SE8102193L (en) THERAPEUTIC ACTIVE ORGANIC ASSOCIATION AND ITS USE
NO912410L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLE DERIVATIVES.
DK275488D0 (en) indolone derivatives
NO155244C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-SUBSTITUTED-1,2-DIHYDRO-3H-PYRROLO- (1,2-A) -PYRROL-1-CARBOXYL ACIDS FROM THEIR SIMILAR NITRILS.
ATE161725T1 (en) USE OF PHOSPHATE DIESTERS TO TREAT RETINA DISEASES
NO168037C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PURIN DERIVATIVES.
NO951966L (en)
DE69007065D1 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
ATE183088T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF SKIN DISEASES
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
NO974267L (en) Aminotetraline derivative for the treatment of cardiovascular diseases
MX9603477A (en) MYCOPHENOLIC ACID 4-AMINO 6-SUBSTITUTED AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY.
NO177495C (en) Analogous Process for Preparation of Therapeutically Active Glycerine Derivatives
DK360388A (en) MEDICINE FOR TREATMENT OF HEART INFFICIENCY
DE69713648D1 (en) Benzopyran derivatives and their use for the treatment of heart diseases
NO177705C (en) Analogous Process for Preparing Therapeutically Active Ascorbic Acid Derivatives
NO172491C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANE-ALCOHIC ACID DERIVATIVES
PT769962E (en) METHOD OF ATENUATION OF ARTERIAL STENOSIS
NO974651L (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
DE69411852D1 (en) Indole derivatives, their salts and medicines containing them for the treatment of heart diseases
FI883730A0 (en) ETRAR OCH TIOETRAR MED THERAPEUTIC EFFECT, FRAMSTAELLNING AV DESSA OCH PHARMACEUTICAL SAMMANSAETTNINGAR SOM INNEHAOLLER DEM.
DE69429447D1 (en) USE OF 2-AMINOPURINE DERIVATIVES FOR TREATMENT AND PROPHYLAXIS OF HUMAN HERPESVIRUS 7 INFECTIONS